Botulinum neurotoxin A (BoNT-A) is a useful medication for the reduc-tion of muscle overactivity in the upper limb(s) of children with cerebral palsy. The method for BoNT-A delivery, dose, and muscle localization criteria are established. Children who are being treated require appropriate assessment at the impairment and activity levels of functioning. Once injected, children require specific therapy delivered by an occupational therapist according to the specified goals that are set out prior to injection, by the child, family, and health-care workers. BoNT-A injection offers the child with cerebral palsy a period of reduced muscle overactivity and is a useful adjunct to evidence-based upper-limb therapy.
|Title of host publication||International Handbook of Occupational Therapy Interventions, Second Edition|
|Number of pages||12|
|Publication status||Published - 1 Jan 2015|
- Botulinum Neurotoxin